RNS Announcement
The Monks Investment Trust PLC
(MNKS)
Legal Entity Identifier:
213800MRI1JTUKG5AF64
Results for the year to 30 April
2024
NAV (borrowings at fair value)
*
|
+17.6%
|
NAV (borrowings at par) *
|
+17.7%
|
Share Price*
|
+19.1%
|
Index†
|
+19.1%
|
Source: LSEG / Baillie Gifford. All
figures are total return*. See disclaimer at the end of
this announcement.
* Alternative Performance Measure - see Glossary of terms and
Alternative Performance Measures at the end of this
announcement.
† Comparative index: FTSE World Index (in sterling
terms).
The following is the Preliminary
Results Announcement for the year to 30 April 2024 which was
approved by the Board on 1 July 2024.
Chairman's Statement
Performance
During the year the net asset value
('NAV') total return, with borrowings calculated at fair value, was
+17.6%. The share price total return was +19.1%, matching the FTSE
World Index return of +19.1%. The second half of the year provided
much stronger returns than the first half, with a NAV total return
of +21.6% and a share price total return of +28.5% compared to
+16.6% from the index. This is an encouraging return to positive
relative performance after the last two years' declines; but we are
well aware that on a NAV basis, this is the third year of
underperformance.
The Managers have been actively
repositioning the Company's portfolio, identifying growth equities
with the characteristics to perform well even in the more
challenging economic environment. The essential thesis of the
Managers' original investment approach is unchanged, but the
experience gained in the last few years has refined its
application, particularly focusing on valuation
discipline.
Capital allocation
The Company's shares traded at a
discount to net asset value throughout the year. The Board has been
active in buying shares in the open market. Having issued shares
when Monks' shares traded at a premium to net asset value, we
believe that it is our obligation to be ready buyers at a discount.
Buying the Company's own shares at a discount to NAV enhances NAV
per share for ongoing shareholders. Buybacks also improve
short-term liquidity in the Company's shares. We believe that the
underlying portfolio is attractive enough for our shares to trade
at close to or above NAV.
Over the course of the Company's
financial year, we bought 16.7 million shares, at an average
discount of 10.4% and a cost of £172.9 million. Since we commenced
this active programme in January 2022, we have bought back 39.0
million shares at a cost of £406.0 million; representing 16.5% of
the Company's issued share capital as at 31 December 2021 and one
of the highest buybacks as a percentage of issued share capital in
the global equity sector. At the year-end, the discount had
narrowed to 8.5% (30 April 2023 - 9.7%). The Board will continue
its buyback policy as a key part of its overall capital
allocation.
Borrowings and gearing
Our investment trust structure
allows gearing, which should enhance long-term returns. The Board's
strategic borrowing target is 10%. It is expected that effective
gearing will be maintained in the range of minus 15% to plus 15%.
Gearing rose moderately from 5.3% at the start of the year to 6.8%
by the end as a result of obtaining new private placement debt and
funding buybacks.
In December 2023, the Company issued
four tranches of private placement debt totalling £73 million,
three euro-denominated, and one in yen, across a range of
maturities from 2030 to 2037. This was used in part to repay higher
cost floating rate bank debt. The Company's structural debt with a
current weighted average interest rate of 2.74% is supplemented by
a revolving, floating rate facility with National Australia Bank
Limited which expires in November 2024. At the year end, £50
million (30 April 2023 - £75 million) of this £150 million facility
was drawn. The Board values the flexibility offered by the bank
loan and will consider a renewal of this facility later this
year.
Management expenses
Monks remains competitive on fees
and expenses: keeping fees as low as possible maximises the
long-term returns to shareholders. The total ongoing charges ratio
for the year to 30 April 2024 was 0.44%, up marginally from 0.43%
in the prior year. The current tiered management fee scale should
ensure that all shareholders will benefit from economies of scale
as assets grow.
Earnings and dividend
Monks invests with the aim of
maximising capital growth rather than income. All operating costs
are charged to the Revenue Account. The Board's policy is to pay
the minimum dividend required to maintain investment trust status.
Retained earnings are reinvested in the portfolio. In order to
build in headroom for further buybacks that would reduce the shares
in issue qualifying for dividends, the Board is recommending that a
single final dividend of 2.10p be paid, compared to 3.15p last
year, to ensure that the amount retained for the year does not
exceed that permissible.
Addressing sustainability and fossil fuel
investments
Many shareholders will be aware of
the public debate surrounding investments in fossil fuels. The
Board and the Managers take their stewardship responsibilities very
seriously. Environmental, Social, and Governance (ESG) factors are
intrinsically linked with long-term investing. The Managers embed
the analysis of these factors into their core research when
searching for high-quality growth companies. They are supported by
a dedicated ESG analyst who assists with the ongoing stewardship of
each holding; he is part of a wider team of more than 40 people.
The objective is not to seek perfection but to focus on materiality
and the direction of travel. Engagement can encourage responsible
behaviour and meaningful change. The Company's direct investments
in businesses with fossil fuel related activities totalled 2.6%
versus 4.8% for the index at the year end.
Engaging with portfolio companies
Throughout the year, the Managers
regularly engage with portfolio companies. An interesting case
study is the building materials company, CRH, which is the largest
contributor to the portfolio's carbon footprint. However, CRH's
products are essential for investments in our built environment,
including new energy infrastructure crucial for the energy
transition. The Managers have engaged with CRH about their carbon
emissions for an extended period, playing a crucial role in the
company becoming a leader in lower-carbon solutions and setting
some of the industry's most ambitious carbon reduction
plans.
Importantly, if the Managers believe
that insufficient progress is being made relating to important ESG
factors, they will sell a stock. A recent example includes the
miner Rio Tinto, where concerns regarding governance and the
approach to environmental impact were not adequately addressed. The
Company has since sold its holding.
The
Board
The Board is cognisant of the need
to ensure regular refreshment of its composition, whilst also
maintaining continuity and corporate memory. In particular, we
believe that succession should incorporate adequate handover
periods. As part of this ongoing succession planning, the Directors
reviewed the skills and experience of the Board; considered recent
and anticipated developments in the commercial and regulatory
landscape; and appointed Cornforth Consulting to commence the
search for two new Directors. As a result of this process, the
Board is pleased to welcome Randeep Grewal and Stacey
Parrinder-Johnson, who were appointed with effect from 1 March
2024. They bring diverse investment industry experience and breadth
of perspective to the Board. We expect their appointments to
strengthen further its debate and challenge of the
Managers.
Jeremy Tigue, who joined the Board
in September 2014 will not offer himself for re-election at the
forthcoming Annual General Meeting. Belinda Richards took over from
Jeremy as Senior Independent Director in December 2023, and Claire
Boyle will succeed him as Audit Committee Chair. We will miss his
wise counsel and depth of knowledge; he has been a super colleague
for all of us and a model non-executive.
My colleagues have asked that I
remain Chairman after this AGM; and the Board will make an
announcement about future succession plans in due
course.
The
Managers
The Board believes that Baillie
Gifford is an impressive investment house, with excellent minds
applied to finding the best way of profiting from the accelerating
change in the global economy. We have continued to bolster the lead
investment team, with Baillie Gifford's joint managing partner
Malcolm MacColl and partner Spencer Adair being joined by Helen
Xiong as deputy portfolio manager. Helen is an investment manager
in Baillie Gifford's Global Alpha Team and a partner in the
firm.
We are encouraged by the robustness
of analysis of the portfolio, and its diversified distillation of
Baillie Gifford's best ideas. It is well placed to deliver superior
returns to shareholders, whatever the short-run impact of inflation
concerns, interest rates or geopolitical risk. It is encouraging
that recent performance has improved significantly, and that the
portfolio outperformed its comparative index in the second half of
the year.
Outlook
The Board shares the enthusiasm of
our Managers for the underlying portfolio. Although our portfolio
is a growth portfolio it has very few loss-making firms. There are
ideas from across the economy, not just in technology. We have very
limited exposure to unquoted companies. The valuation premium over
the market is quite narrow, on a range of measures, whereas the
expected growth in revenues and profits for portfolio companies is
much higher than the market's overall growth rate. We are not
reliant on a small number of big winners. We believe that Monks is
the growth portfolio that all investors can consider to be a core
holding.
Annual General Meeting
Shareholders who have been
accustomed to attending the Company's AGM for many years in the
same venue should take note of a change of location. This year, the
AGM will be held on Tuesday 10 September 2024 at the Royal
Institution, 21 Albemarle Street, London W1S 4BS, at the slightly
later time than previously of 11.30 am. We look forward to
welcoming shareholders there.
In line with last year's procedure,
the Board intends to hold the AGM voting on a poll, rather than on
a show of hands, so encourages all shareholders to exercise their
votes at the AGM by completing and submitting a form of proxy. We
recommend that shareholders monitor the Company's website at
monksinvestmenttrust.co.uk
where any updates regarding the meeting will be posted. Market
announcements will also be made in the event of any change to the
scheduled arrangements.
Should shareholders have questions
for the Board or the Managers, or any queries as to how to vote,
they are welcome as always to submit them by email to trustenquiries@bailliegifford.com or
call 0800 917 2112. For shareholders investing through a platform,
the AIC guidance on how to vote shares in advance or obtain the
documentation necessary to vote in person at the AGM, may be of
assistance: theaic.co.uk/how-to-vote-your-shares.
KS Sternberg
Chairman
1 July 2024
Past performance is not a guide to
future performance. Total return information is sourced from
Baillie Gifford/LSEG. See disclaimer at the end of this
announcement. For a definition of terms used see Glossary of terms
and Alternative Performance Measures at the end of this
announcement.
Managers' Review
The past year in financial markets
may best be described as a 'game of two halves'. The first was a
cagey and nervous affair. The dominant narrative was uncertainty
relating to the prospect of a US recession. The second half was
much more encouraging. Against a backdrop of growing optimism as
inflation stabilised and central banks paused interest rate
increases, investors continued to recognise the transformational
potential of artificial intelligence (AI). This manifested most
obviously in the share prices of some of the world's largest
technology stocks (several of which we own within Monks). Equity
indices rallied, driven by these companies, and, in some cases, hit
new highs.
Similarly, the second half of our
financial year delivered markedly stronger results than the first.
A net asset value (NAV) total return* of +21.6% (the index
delivered +16.6%) compares strongly to the first half of the year.
This was underpinned by solid operational progress for our
portfolio: the holdings saw earnings growth of +12% compared to
-0.8% for the index. Our investments continue to adapt positively
to the operating backdrop (see 'Performance' section
below).
Conviction in our approach
While we have adapted the way we
manage the portfolio, such as strengthening the analytical inputs
around valuations and stock correlations, the core approach to
managing Monks remains consistent. We select stocks based on their
fundamental attractions without reference to the index (over 80% of
the portfolio is different to the index); we seek to invest in a
diversified collection of companies that can deliver superior
levels of earnings growth; and we strive to allow compounding to
work its magic by being patient (our turnover is 15%, implying an
average holding period of 6 years). We continue to have absolute
conviction that this approach will deliver attractive long-term
returns for shareholders.
The foundation of our conviction
lies in the portfolio's financial characteristics. We therefore
make no apologies for citing (as we have in past reports) the
strength of our holdings' balance sheets, superior gross margins,
and stronger forecast earnings growth. This is accompanied by a
valuation premium consistent with our long-run average (+23% on a
forward price-to-earnings basis).
Growth companies excite us. From AI,
to gravel, to storm drains, to digital payments, Monks seeks to
give shareholders exposure to the world's leading beneficiaries of
change, whatever the sector, wherever in the world.
Performance
The Global Alpha team has managed
Monks for nine years. Over this period, the fair value NAV total
return has been +166.6%* (share price +175.6%*) compared to the
comparative index (FTSE World) which returned +170.8%*. In the
twelve months to the end of April, the portfolio underperformed the
comparative index (FTSE World) by -1.5%, delivering a NAV total
return of +17.6% (share price +19.1%) against the index total
return of +19.1%.
Our insurance and healthcare
holdings were among the largest detractors from relative
performance. The share prices of AIA, Ping An and Prudential
(totalling 3.0% of the portfolio) fell by an average of -34% in the
period. The lingering effect of the pandemic on the Chinese economy
curtailed active selling opportunities (as sales force activity
remains below pre-pandemic levels) and weakened consumer demand. We
have sold our positions in Ping An and Prudential. We believe that
AIA is best placed to take advantage of the significant structural
long-term growth opportunity that remains in China (and across Asia
more broadly), where the 'protection gap' is large. AIA is seeing
demand return, is growing its salesforce once again (having cut
back during COVID), and has recently been granted licenses in five
new Chinese territories expanding its addressable
market.
The healthcare sector is navigating
a challenging period against a backdrop of excess inventory
build-up following the pandemic (which has suppressed demand) and a
much more difficult funding environment for drug developers. In
relation to the latter, we believe this supports our position in
Royalty Pharma, a provider of capital to late-stage drug
developers. Whilst its share price has been weak, down -20% in the
year, we continue to believe that operational progress is on track.
Its stream of royalties from its existing portfolio of drugs
continues to grow healthily and the company is deploying capital
well ahead of the pace needed to support double-digit growth rates
(US$1.6bn deployed in the latest quarter, compared to a 5-year
average of US$2bn annually).
We have sold Novocure (cancer
treatment). Our central expectation was that it could successfully
expand its addressable market by applying its tumour treatment
field technology, designed to treat solid-state brain tumours, to
cancers affecting other vital organs. Setbacks in recent clinical
trials have negatively affected the probabilities of success and
weakened our conviction in the investment case.
The majority of the portfolio
holdings are adapting and executing well. Several holdings have
proven their adaptability by exerting exceptional pricing power and
have been the strongest positive contributors to portfolio return.
Martin Marietta (aggregates and building supplies) is a case in
point. It has been able to increase aggregate pricing significantly
(+14% year-on-year†) and deliver record levels of profitability. It
has been a similar story at CRH (cement and building supplies),
which was the second-largest contributor to portfolio return.
Elsewhere, Meta (social media) as one of our 'Stalwart' growth
holdings, has unleashed the power of its advertising estate by
leveraging its growing AI capabilities to improve its utility to
merchants. This has driven demand for its advertising capacity and
gradually improved pricing. In conjunction with sensible cost
control and more disciplined growth spending, Meta has delivered a
doubling of net income (+117%) year-over-year†.
Others have executed flawlessly.
Rapid Growth holding DoorDash, the leading US food delivery
platform, was the third largest positive contributor to the
portfolio's return. The company's commitment to improving its
offerings for consumers, merchants, and delivery riders (known as
Dashers) has propelled monthly active users to a record high,
alongside a significant increase in average order frequency. It now
has almost two-thirds of the online meal delivery market in the US
and grew revenues at +27% year-on-year#. DoorDash is making strong progress
in new markets too, including online grocery delivery, as it seeks
to become the convenience platform of choice for consumers in the
US.
Innovation beyond the obvious
Whilst markets have been narrowly
focused over the past year, we have continued to embrace a wide
array of opportunities. These span both digital and physical
spheres - from enterprise cloud computing and digital payments to
telegraph poles and HVAC (heating, ventilation, and air
conditioning) installation. We expect market returns to broaden
over time. The Monks portfolio should benefit as it is aligned with
deep structural trends that will support long-term
growth.
By way of illustration, we highlight
below some of these structural trends and related changes to the
portfolio over the last year:
Digital Payments - the digital
payments market has developed hugely since the first consumer
payment was recorded in 1994 (a CD copy of Sting's 'Ten Summoner's
Tales' for US$12.48 on NetMarket, for the trivia aficionados among
you). Indeed, the value of global digital payment transactions has
doubled (to over US$6 trillion) in the past 5 years alone and there
remains much to go for. We have purchased a new position in Block
which owns Cash App, the most popular finance application in the US
with over 80 million users. Started as a peer-to-peer payments
application, it has developed into a fully-fledged consumer 'app'
offering multiple services. The other part of its offering is its
'Square' point-of-sale hardware, which enables merchants (often
small or micro businesses without an online presence) to accept
digital payments. It is a simple, convenient, and easy-to-use
solution for merchants to accept a wide variety of digital
payments. We are excited about Block's potential to integrate these
two offerings and build significant long-term value. Indeed, we
have added to the position since purchase. The portfolio has
exposure to a range of other digital payment businesses, including
Mastercard, the rapidly growing MercadoPago (operated by
MercadoLibre) in South America, and Adyen, the Dutch payments
business (to which we added in the period).
Semiconductors - technological
advancement in semiconductors is driving the exponential
acceleration of computing power. This has potentially profound
implications for what computers are able to do in the future, from
driving cars autonomously (at scale) to producing music, content
and independently writing computer code. We have deliberately grown
the portfolio's exposure to the semiconductor industry (now 10% of
the portfolio) over the past couple of years. In our interim
report, we underlined our enthusiasm for the purchase of NVIDIA as
the leading global designer of graphics processing units (GPUs), a
key enabler of artificial intelligence (AI) applications. In recent
months we have added holdings in semiconductor companies Texas
Instruments and Samsung Electronics. Growth in both cases will be
driven by the secular trends towards greater electrification (for
example in the automotive market), the use of consumer electronics
(think smartphones, laptops, and tablets), and the ongoing
build-out of data centres to support increasing cloud computing
capacity.
Healthcare - the long-term
drivers of the need for healthcare are clear. The global number of
people aged over 60 will double by 2050. The number of people over
80 will triple. As we age, we consume much more healthcare. We
added a position in the Danish insulin business, Novo Nordisk. It
has seen a recent rapid transformation from a steadily compounding
business focusing on diabetes care and clotting, to leading the way
in GLP-1 weight-loss drugs. Novo's drug, Wegovy, has opened a huge,
global market and is addressing one of the world's biggest health
challenges. The opportunity could reach hundreds of millions of
individuals who are clinically obese, as well as unlock further
opportunities by reducing the long list of health complications
that come with obesity (heart disease, certain types of cancer,
liver disease etc).
Infrastructure - we have
continued to invest where companies may be beneficiaries of an
'Infrastructure Upgrade', particularly in the US. There are several
factors including re-shoring trends and infrastructure spending
(supported by legislation like the Inflation Reduction Act) which
are likely to support a material uptick in capital spending on
areas including roads, energy, and digital networks. We wrote about
our enthusiasm for Comfort Systems, the HVAC installer, in our
interim update, and we recently established a position in the
Canadian company Stella-Jones. It is North America's largest
manufacturer of pressure-treated wood products. The growth case
rests on its core product, wooden utility poles, used for
electrical and communications infrastructure. For the US to
decarbonise its energy systems and have a chance of achieving its
Net Zero ambitions, substantial investment will be required in its
national power grid. We believe volume growth and pricing power
will boost profitability in the coming years.
Remaining ambitious
We have sold several positions as we
seek to upgrade the portfolio's growth prospects. Some of these
generated strong returns for the portfolio, but the likelihood of
similar returns in the future looked unlikely. Examples include the
semiconductor testing equipment business, Teradyne (up five-fold
since purchase), and the governance and data services business
Broadridge (up two-fold since purchase). In other cases, despite
signs of some progress, our patience was exhausted with the likes
of Adidas (sports apparel) and Wayfair (online furniture retail).
Adidas' new management team must reposition the Adidas brand and
assess how to tap into large markets like China, where they are
currently being outcompeted by Nike and domestic brands. Wayfair
has successfully restructured its debt position, but we have
reservations that the business can return to volumes supportive of
margin expansion and attractive profit growth. There was also a
higher number of complete sales of smaller positions within the
portfolio. We chose to sell several holdings inherited as part of
the rollover of assets from the Independent Investment Trust in
November 2022. These included travel businesses Jet2 (travel) and
On the Beach (online travel). Strong travel-related demand has
returned post-pandemic. The share prices of these companies now
better reflect their long-term growth potential so we have
redeployed the proceeds elsewhere.
Governance and Sustainability
The building blocks of our
investment philosophy - bottom-up stock-level research and
long-termism - chime with an increasing focus on stewardship and
focus on Environmental, Social, and Governance factors. We
understand that businesses operate in a complex and dynamic world
where their activities may have positive and negative impacts.
There are no shortcuts. We believe that getting to know companies
on a case-by-case basis is essential as we seek to understand their
unique circumstances and assess material factors that may influence
their sustainability. This directly impacts our assessment of
holdings within the Monks portfolio.
Our latest thinking can be found
within our dedicated
Monks Stewardship Report on our
website.
Improving our team
We are pleased that the Board agreed
to appoint Helen Xiong as a Deputy Manager of Monks with effect
from 1 July 2024. Helen is a partner of Baillie Gifford and has
been at the firm since 2008. She works closely with us on Baillie
Gifford's Global Alpha strategy and has contributed strongly to
ideas that we have adopted for the portfolio in recent years
including DoorDash (food delivery) and, more recently, Block
(payments).
Outlook
Across our portfolio, companies are
successfully fine-tuning operations to adjust to present
conditions, while continuing to invest for the future. This has
translated into strong delivered and forecast earnings growth.
Pleasingly, there are encouraging signs that investment markets -
against a backdrop of stabilising inflation and interest rates -
are more willing to recognise this, and relative performance has
begun to rebound strongly. Our optimism is reflected in our
decision to raise medium-term debt (£73m) in the private placement
market (net gearing was 6.8% at year end). Our blended cost of
fixed rate borrowing is now 2.74%, which we consider to be a low
hurdle when set against future investment opportunities.
As we look forward, what is most
exciting is that the rate of change and technological development
is accelerating and underpins a growing, and often
underappreciated, opportunity set. By virtue of our willingness to
take a wide-angled view of growth (defined by our growth profiles -
Stalwart, Rapid and Cyclical growth), we have the latitude to
invest beyond the obvious. This allows us to harness the growth
potential of lesser-known but nevertheless exceptional growth
companies. We are therefore enthusiastic about the potential of
SiteOne Landscape Supply and its ability to consolidate the
wholesale landscaping supply market in the US, while concurrently
embracing the latest advancements in semiconductor design by owning
positions in the likes of NVIDIA and ASM International. Our
portfolio reflects an eclectic and growing opportunity set and we
are confident that it will deliver for shareholders in the years
ahead.
Spencer Adair
Malcolm MacColl
Helen Xiong
1 July 2024
* Total returns from 31 March 2015
to 30 April 2024.
† Q1 2024 versus Q1 2023.
# Q4 2023
versus Q4 2022.
Past performance is not a guide to
future performance.
Total return information is sourced
from Baillie Gifford/LSEG. See disclaimer at the end of this
announcement.
For a definition of terms used see
Glossary of terms and Alternative Performance Measures at the end
of this announcement.
The Managers' core investment
beliefs
We believe the following features of
Monks provide a sustainable basis for adding value for
shareholders.
Active management
· We
invest in attractive companies using a 'bottom-up' investment
process. Macroeconomic forecasts are of relatively little interest
to us.
· High
active share* provides the potential for
adding value.
· We
ignore the structure of the index - for example the location of a
company's HQ and therefore its domicile are less relevant to us
than where it generates sales and profits.
· Large
swathes of the market are unattractive and of no interest to
us.
· As
index agnostic global investors we can go anywhere and only invest
in the best ideas.
· As the
portfolio is very different from the index, we expect portfolio
returns to diverge - sometimes substantially and often for
prolonged periods.
Committed growth investors
· In the
long run, share prices follow fundamentals; growth drives
returns.
· We aim
to produce a portfolio of stocks with above average growth, this in
turn underpins the ability of Monks to add value.
· We
have a differentiated approach to growth, focusing on the type of
growth that we expect a company to deliver. All holdings fall into
one of three growth categories, as set out below.
· The
use of these three growth categories ensures a diversity of growth
drivers within a disciplined framework.
Long-term perspective
· Long-term holdings mean that company fundamentals are given
time to drive returns.
· We
prefer companies that are managed with a long-term mindset, rather
than those that prioritise the management of market
expectations.
· We
believe our approach helps us focus on what is important during the
inevitable periods of underperformance.
· Short-term portfolio results are random.
· As
longer-term shareholders we are able to have greater influence on
environmental, social and governance matters.
Dedicated team with clear decision-making
process
· Senior
and experienced team drawing on the full resources of Baillie
Gifford.
· Alignment of interests - the investment team responsible for
Monks all own shares in the Company.
Portfolio construction
· Investments are held in three broad holding sizes, as set out
below.
· This
allows us to back our judgement in those stocks for which we have
greater conviction, and to embrace the asymmetry of returns through
'incubator' positions in higher risk/return stocks.
· 'Asymmetry of returns' - some of our smaller positions will
struggle and their share prices will fall; those that are
successful may rise many fold. The latter should outweigh the
former.
Low
cost
· Investors should not be penalised by high management
fees.
· Low
turnover and trading costs benefit shareholders.
* For a
definition of terms see Glossary of terms and Alternative
Performance Measures at the end of this document
Investment portfolio by growth
category as at 30 April 2024*
Holding size
|
Growth
stalwarts
|
34.4%
|
Rapid
growth
|
34.4%
|
Cyclical
growth
|
31.2%
|
|
(c.10% p.a. earnings growth)
|
|
(c.15% to 25% p.a. earnings growth)
|
|
(c.10% to 15% p.a. earnings growth
through a cycle)
|
|
|
Company characteristics
¾
Durable franchise
¾
Deliver robust profitability in most macroeconomic
environments
¾
Competitive advantage includes dominant local
scale, customer loyalty and strong brands
|
|
Company characteristics
¾
Early stage businesses with vast growth
opportunity
¾
Innovators attacking existing profit pools or
creating new markets
|
|
Company characteristics
¾
Subject to macroeconomic and capital cycles with
significant structural growth prospects
¾
Strong management teams highly skilled at capital
allocation
|
|
Highest conviction holdings
c.2.0% each
Total: 45.2%
|
Microsoft
|
3.6
|
Amazon.com
|
3.5
|
Martin Marietta Materials
|
3.8
|
Meta Platforms
|
3.5
|
The Schiehallion Fund
|
2.6
|
Ryanair
|
2.8
|
Elevance Health
|
3.4
|
Reliance Industries
|
2.4
|
CRH
|
2.7
|
Moody's
|
2.6
|
Prosus
|
2.2
|
TSMC
|
2.3
|
Service Corporation International
|
2.3
|
NVIDIA
|
1.7
|
|
|
Mastercard
|
2.1
|
DoorDash
|
1.6
|
|
|
Alphabet
|
2.1
|
|
|
|
|
|
|
|
|
|
|
Average sized holdings
c.1.0% each
Total: 36.4%
|
Analog Devices
|
1.3
|
The Trade Desk
|
1.2
|
Royalty Pharma
|
1.1
|
Arthur J. Gallagher
|
1.2
|
Novo Nordisk
|
1.1
|
Atlas Copco
|
1.0
|
Pernod Ricard
|
1.2
|
Cloudflare
|
1.0
|
BHP Group
|
1.0
|
AIA
|
1.1
|
Shopify
|
1.0
|
Advanced Drainage Systems
|
1.0
|
Olympus
|
1.0
|
Block
|
1.0
|
Eaton
|
1.0
|
Texas Instruments
|
0.9
|
HDFC
|
1.0
|
Richemont
|
0.9
|
S&P Global
|
0.9
|
MercadoLibre
|
1.0
|
Samsung Electronics
|
0.9
|
UnitedHealth
|
0.9
|
Spotify
|
0.9
|
Markel
|
0.8
|
Thermo Fisher Scientific
|
0.8
|
Schibsted
|
0.9
|
Entegris
|
0.8
|
|
|
Alnylam Pharmaceuticals
|
0.8
|
CoStar
|
0.8
|
|
|
Moderna
|
0.7
|
CATL
|
0.8
|
|
|
Netflix
|
0.7
|
CBRE Group
|
0.8
|
|
|
|
Coupang
|
0.7
|
SiteOne Landscape Supply
|
0.7
|
|
|
|
Alibaba
|
0.7
|
SMC
|
0.7
|
|
|
|
B3 Group
|
0.7
|
ASM International
|
0.7
|
|
|
|
|
|
Comfort Systems USA
|
0.7
|
|
|
|
|
|
|
|
Incubator Holdings
c.0.5% each
Total: 18.4%
|
Walt Disney
|
0.6
|
ByteDance
|
0.6
|
Epiroc
|
0.6
|
Shiseido
|
0.5
|
Sea Limited
|
0.5
|
Nexans
|
0.6
|
Advanced Micro Devices
|
0.5
|
PDD Holdings
|
0.5
|
Floor & Décor Holdings
|
0.5
|
LVMH
|
0.5
|
Stripe
|
0.5
|
Albemarle
|
0.5
|
Sysmex
|
0.5
|
Mobileye
|
0.5
|
Nippon Paint
|
0.5
|
Topicus.com
|
0.5
|
Epic Games
|
0.4
|
Pool Corporation
|
0.5
|
Adobe Systems
|
0.4
|
ICICI Prudential Life Insurance
|
0.4
|
YETI Holdings
|
0.4
|
Chewy
|
0.4
|
Datadog
|
0.4
|
Bellway
|
0.4
|
Stella-Jones
|
0.4
|
Adevinta Asa
|
0.4
|
Brunswick Corp
|
0.4
|
Certara
|
0.3
|
Genmab
|
0.4
|
Rakuten
|
0.4
|
Neogen Corp
|
0.3
|
Li Auto
|
0.3
|
Ashtead Group
|
0.4
|
Sartorius Stedim Biotech
|
0.3
|
Adyen
|
0.3
|
Sands China
|
0.4
|
Hoshizaki Corp
|
0.3
|
Space Exploration Technologies
|
0.3
|
Woodside Energy Group
|
0.2
|
|
|
CyberAgent
|
0.3
|
Silk Invest Africa Food Fund
|
0.1
|
|
|
Tesla
|
0.3
|
Sberbank of Russia
|
-
|
|
|
Lemonade
|
0.3
|
|
|
|
|
Staar Surgical
|
0.2
|
|
|
|
|
Ant International
|
0.2
|
|
|
|
|
BIG Technologies
|
0.2
|
|
|
|
|
AeroVironment
|
<0.1
|
|
|
|
|
Illumina CVR
|
<0.1
|
|
|
|
|
Abiomed CVR
|
-
|
|
|
|
|
|
|
|
|
* Excludes net liquid assets.
Portfolio positioning as at 30
April 2024*
Geographical*
|
At
30 April
2024
%
|
At
30 April
2023
%
|
North America
|
57.4
|
52.4
|
Continental Europe
|
17.7
|
16.3
|
Emerging Markets
|
12.6
|
10.9
|
Japan
|
4.2
|
5.2
|
United Kingdom
|
3.6
|
8.6
|
Developed Asia
|
3.2
|
4.9
|
Net liquid assets†
|
1.3
|
1.7
|
Total assets†
|
100.0
|
100.0
|
Sectoral*
|
|
At
30 April
2024
%
|
At
30 April
2023
%
|
Technology
|
28.5
|
21.6
|
Consumer discretionary
|
20.3
|
22.4
|
Industrials
|
18.2
|
13.3
|
Healthcare
|
11.8
|
12.5
|
Financials
|
11.7
|
17.8
|
Energy
|
2.6
|
2.6
|
Basic materials
|
1.9
|
4.0
|
Real estate
|
1.6
|
1.8
|
Consumer staples
|
1.2
|
2.3
|
Telecommunications
|
0.9
|
-
|
Net liquid assets†
|
1.3
|
1.7
|
Total assets†
|
100.0
|
100.0
|
* Expressed as a percentage of
total assets.
†For a definition of terms used see Glossary of terms and
Alternative Performance Measures at the end of this
announcement.
List of Investments at 30 April
2024
Name
|
Business
|
Value
£'000
|
% of total
assets*
|
Martin Marietta Materials
|
Cement and aggregates manufacturer
|
106,974
|
3.7
|
Microsoft
|
Software and cloud computing
|
102,564
|
3.6
|
Meta Platforms
|
Social networking website
|
99,850
|
3.5
|
Amazon.com
|
Online retailer and cloud computing
platform
|
98,576
|
3.4
|
Elevance Health
|
Healthcare insurer
|
97,183
|
3.4
|
Ryanair
|
Low cost European airline
|
79,927
|
2.8
|
CRH
|
Diversified building materials
|
78,023
|
2.7
|
The Schiehallion Fund #
|
Global unlisted growth equity investment
company
|
73,796
|
2.6
|
Moody's
|
Credit rating agency
|
72,668
|
2.5
|
Reliance Industries
|
Indian energy conglomerate
|
69,172
|
2.4
|
TSMC
|
Semiconductor manufacturer
|
65,975
|
2.3
|
Service Corporation
International
|
Funeral and crematoria services
|
65,691
|
2.3
|
Prosus
|
Media and ecommerce
|
61,462
|
2.1
|
Mastercard
|
Electronic payments network and related
services
|
60,789
|
2.1
|
Alphabet
|
Online search engine
|
59,533
|
2.1
|
NVIDIA †
|
Graphics processing, gaming, AI
technology
|
49,131
|
1.7
|
DoorDash
|
Online commerce platform
|
45,626
|
1.6
|
Analog Devices
|
Integrated circuits
|
37,576
|
1.3
|
Arthur J. Gallagher
|
Insurance broker
|
33,600
|
1.2
|
Pernod Ricard
|
Global spirits manufacturer
|
33,392
|
1.2
|
The Trade Desk
|
Advertising technology
|
32,887
|
1.1
|
AIA
|
Asian life insurer
|
30,975
|
1.1
|
Novo Nordisk †
|
Diabetes and weight loss treatment
|
30,953
|
1.1
|
Royalty Pharma
|
Biopharmaceutical royalties
portfolio
|
30,491
|
1.1
|
Olympus
|
Optoelectronic products
|
29,854
|
1.0
|
Cloudflare
|
Cloud based IT services
|
29,854
|
1.0
|
Shopify
|
Online commerce platform
|
29,783
|
1.0
|
Atlas Copco
|
Industrial equipment
|
29,717
|
1.0
|
Block †
|
Financial technology
|
29,085
|
1.0
|
HDFC
|
Indian mortgage provider
|
28,106
|
1.0
|
BHP Group
|
Mineral exploration and production
|
27,910
|
1.0
|
MercadoLibre
|
Latin American ecommerce platform
|
27,844
|
1.0
|
Advanced Drainage Systems
|
Manufacturer of pipes and drainage
systems
|
27,182
|
0.9
|
Eaton
|
Industrial engineering products
|
27,067
|
0.9
|
Texas Instruments †
|
Semiconductors
|
26,922
|
0.9
|
Richemont
|
Luxury goods
|
26,916
|
0.9
|
Spotify
|
Online music streaming service
|
26,692
|
0.9
|
S&P Global
|
Credit rating agency
|
25,550
|
0.9
|
UnitedHealth †
|
Healthcare
|
25,232
|
0.9
|
Samsung Electronics †
|
Multinational technology producer
|
25,048
|
0.9
|
Schibsted
|
Media and classified advertising
platforms
|
24,222
|
0.8
|
Markel
|
Markets and underwrites speciality insurance
products
|
23,974
|
0.8
|
Entegris
|
Supplier of materials to high-tech
industries
|
23,533
|
0.8
|
CoStar
|
Commercial property portal
|
23,339
|
0.8
|
Thermo Fisher Scientific
|
Scientific instruments, consumables and
chemicals
|
22,744
|
0.8
|
CATL †
|
Battery manufacturer
|
22,310
|
0.8
|
Alnylam Pharmaceuticals
|
RNA interference based biotechnology
|
22,126
|
0.8
|
CBRE Group
|
Commercial real estate
|
22,026
|
0.8
|
Moderna
|
Drug discovery using mRNA technology
|
20,781
|
0.7
|
Netflix
|
Subscription service for TV shows and
movies
|
20,488
|
0.7
|
SiteOne Landscape Supply
|
US distributor of landscaping
supplies
|
20,313
|
0.7
|
SMC
|
Factory automation equipment
|
20,176
|
0.7
|
Coupang
|
South Korean ecommerce
|
19,922
|
0.7
|
ASM International
|
Vapour deposition technology for
semiconductors
|
19,918
|
0.7
|
Alibaba
|
Ecommerce
|
19,274
|
0.7
|
B3 Group
|
Brazilian stock exchange operator
|
18,954
|
0.7
|
Comfort Systems USA †
|
HVAC systems and solutions
|
18,794
|
0.6
|
ByteDance U
|
Online content platform including
TikTok
|
18,249
|
0.6
|
Walt Disney †
|
Media and theme parks
|
17,602
|
0.6
|
Epiroc
|
Construction and mining machinery
|
17,410
|
0.6
|
Nexans
|
Manufacturer of cables and electrical
parts
|
16,869
|
0.6
|
Shiseido
|
Japanese cosmetics manufacturer
|
15,335
|
0.5
|
Floor & Décor Holdings
|
Speciality retailer
|
14,601
|
0.5
|
Albemarle
|
Lithium miner
|
14,408
|
0.5
|
Nippon Paint †
|
Japanese paint manufacturer
|
14,273
|
0.5
|
Sea Limited
|
Online and digital gaming
|
14,268
|
0.5
|
Advanced Micro Devices †
|
Semiconductors
|
13,772
|
0.5
|
PDD Holdings †
|
Chinese real estate development
|
13,758
|
0.5
|
LVMH †
|
Luxury goods
|
13,506
|
0.5
|
Sysmex
|
Medical testing equipment
|
13,500
|
0.5
|
Topicus.com
|
Vertical market software and
solutions
|
13,310
|
0.5
|
Pool Corporation
|
Swimming pool supplies
|
13,296
|
0.5
|
Stripe U
|
Payments platform
|
13,093
|
0.4
|
Mobileye †
|
Advanced driver assistance systems (ADAS) and
autonomous driving technologies
|
12,922
|
0.4
|
Epic Games U
|
Gaming software developer
|
12,688
|
0.4
|
YETI Holdings †
|
Outdoor lifestyle products
|
12,630
|
0.4
|
Bellway
|
Home construction
|
12,441
|
0.4
|
Adobe Systems
|
Software products and technologies
|
12,418
|
0.4
|
ICICI Prudential Life Insurance
|
Life insurance services
|
12,248
|
0.4
|
Datadog
|
Cloud based IT system monitoring
application
|
12,223
|
0.4
|
Brunswick Corp †
|
Recreational boats, marine engines, marine
parts
and accessories
|
12,099
|
0.4
|
Rakuten †
|
Online retail and financial services
|
11,966
|
0.4
|
Chewy
|
Online pet supplies retailer
|
11,691
|
0.4
|
Ashtead Group
|
Industrial equipment rental
|
11,684
|
0.4
|
Sands China
|
Macau casino operator
|
11,410
|
0.4
|
Adevinta Asa
|
Media and classified advertising
platforms
|
11,346
|
0.4
|
Genmab
|
Biotechnology
|
11,332
|
0.4
|
Stella-Jones †
|
Industrial pressure treated wood products
manufacturer
|
10,461
|
0.4
|
Li Auto
|
Chinese EV manufacturer
|
9,929
|
0.3
|
Certara
|
Drug discovery and development
|
9,306
|
0.3
|
Neogen Corp †
|
Food and animal safety products and
services
|
9,260
|
0.3
|
Sartorius Stedim Biotech
†
|
Biotechnology, specialised equipment for
research
|
8,691
|
0.3
|
Adyen
|
Digital payments
|
8,666
|
0.3
|
Space Exploration Technologies
U
|
Space rockets and satellites
|
7,747
|
0.3
|
Hoshizaki Corp
|
Commercial kitchen equipment
manufacturer
|
7,525
|
0.3
|
CyberAgent
|
Japanese internet advertising and
content
|
7,470
|
0.3
|
Tesla
|
Electric cars and renewable energy
solutions
|
7,311
|
0.2
|
Lemonade
|
Data and insurance
|
7,142
|
0.2
|
Staar Surgical
|
Implantable contact lenses
|
6,206
|
0.2
|
Woodside Energy Group
|
Australian gas and oil
|
5,484
|
0.2
|
Ant International U
|
Chinese online payments and financial services
business
|
4,551
|
0.2
|
BIG Technologies
|
Electronic monitoring solutions
|
4,485
|
0.2
|
Silk Invest Africa Food Fund
U
|
Africa focused private equity fund
|
2,452
|
0.1
|
AeroVironment †
|
Small unmanned aircraft and tactical missile
systems
|
1,233
|
<0.1
|
Illumina CVR U
|
Gene sequencing business
|
331
|
<0.1
|
Sberbank of Russia ꟊ
|
Russian commercial bank
|
-
|
-
|
Abiomed CVR
|
Medical implant manufacturer
|
-
|
-
|
Total investments
|
|
2,847,068
|
98.7
|
Net liquid assets*
|
|
37,245
|
1.3
|
Total assets*
|
|
2,884,313
|
100.0
|
Borrowings (at book value)
|
|
(223,176)
|
(7.7)
|
Shareholders' funds
|
|
2,661,137
|
92.3
|
|
Listed
equities
%
|
Schiehallion
Fund #
%
|
Unlisted
securities ‡
%
|
Net liquid
assets*
%
|
Total
assets*
%
|
30 April 2024
|
94.1
|
2.6
|
2.0
|
1.3
|
100.0
|
30 April 2023
|
94.4
|
2.0
|
1.9
|
1.7
|
100.0
|
* For a
definition of terms used see Glossary of terms and Alternative
Performance Measures at the end of this announcement.
U Denotes unlisted (private company)
investment.
† New
purchase during the period. Complete sales during the period were:
Bytes Technology Group, Farfetch, Jet2, Midwich, On the Beach,
Persimmon, Prudential, Redrow, Rio Tinto, Team 17
Group, Wizz Air Holdings, adidas, Deutsche Boerse, Axon Enterprise,
Booking Holdings, Broadridge Financial Solutions, Bumble, Charles
Schwab, Estée Lauder, Exact Sciences, Howard Hughes, Illumina,
Novocure, Snowflake, Teradyne, Wayfair, DENSO, Meituan, Ping An
Insurance.
# The
Schiehallion Fund is managed by Baillie Gifford. The Company's
holdings in The Schiehallion Fund are excluded from its assets when
calculating the management fee.
See note 3 to the Financial
Statements.
ꟊ
Denotes suspended investment.
‡ Includes
holdings in preference shares, ordinary shares and contingent value
rights (CVR).
Baillie Gifford - valuing private
companies
We aim to hold our private company
investments at 'fair value' i.e. the price that would be paid in an
open-market transaction. Valuations are adjusted both during
regular valuation cycles and on an ad hoc basis in response to
'trigger events'. Our valuation process ensures that private
companies are valued in both a fair and timely manner.
The valuation process is overseen by
a valuations committee at Baillie Gifford which takes advice from
an independent third party (S&P Global). The portfolio managers
feed into the process, but the valuations committee owns the
process and the portfolio managers only receive final valuation
notifications once they have been applied.
We revalue the private holdings on a
three-month rolling cycle, with one-third of the holdings
reassessed each month. For investment trusts, the prices are also
reviewed twice per year by the respective investment trust boards
and are subject to the scrutiny of external auditors in the annual
audit process.
Beyond the regular cycle, the
valuations team also monitors the portfolio for certain 'trigger
events'. These may include: changes in fundamentals; a takeover
approach; an intention to carry out an IPO; or changes to the
valuation of comparable public companies. The valuations team also
monitors relevant market indices on a weekly basis and updates
valuations in a manner consistent with our external valuer's
(S&P Global) most recent valuation report where appropriate.
When market volatility is particularly pronounced the team do these
checks daily. Any ad hoc change to the fair valuation of any
holding is implemented swiftly and reflected in the next published
net asset value.
In addition to the 2.0% of the
portfolio holdings in direct private company investments, 2.6% of
the portfolio is in The Schiehallion Fund, a closed ended
investment company investing predominantly in private companies,
which is valued by reference to its publicly available market
price.
Income Statement
For the year ended 30
April
|
Notes
|
2024
Revenue
£'000
|
2024
Capital
£'000
|
2024
Total
£'000
|
2023
Revenue
£'000
|
2023
Capital
£'000
|
2023
Total
£'000
|
Gains/(losses) on investments
|
|
-
|
389,428
|
389,428
|
-
|
(78,421)
|
(78,421)
|
Currency gains
|
|
-
|
1,419
|
1,419
|
-
|
293
|
293
|
Income
|
2
|
29,888
|
-
|
29,888
|
30,211
|
-
|
30,211
|
Investment management fee
|
3
|
(9,431)
|
-
|
(9,431)
|
(8,878)
|
-
|
(8,878)
|
Other administrative expenses
|
|
(1,850)
|
-
|
(1,850)
|
(1,833)
|
-
|
(1,833)
|
Net return before finance costs and
taxation
|
|
18,607
|
390,847
|
409,454
|
19,500
|
(78,128)
|
(58,628)
|
Finance costs of
borrowings
|
|
(8,264)
|
-
|
(8,264)
|
(7,225)
|
-
|
(7,225)
|
Net return on ordinary activities before
taxation
|
|
10,343
|
390,847
|
401,190
|
12,275
|
(78,128)
|
(65,853)
|
Tax on ordinary
activities
|
|
(2,102)
|
(736)
|
(2,838)
|
(1,561)
|
(430)
|
(1,991)
|
Net return on ordinary activities after
taxation
|
|
8,241
|
390,111
|
398,352
|
10,714
|
(78,558)
|
(67,844)
|
Net return per ordinary share
|
4
|
3.68p
|
174.07p
|
177.75p
|
4.70p
|
(34.47p)
|
(29.77p)
|
Note:
Dividends per share paid and
payable in respect of the year
|
5
|
2.10p
|
|
|
3.15p
|
|
|
The total column of this statement
is the profit and loss account of the Company. The supplementary
revenue and capital return columns are prepared under guidance
published by the Association of Investment Companies.
All revenue and capital items in
this statement derive from continuing operations.
A Statement of Comprehensive
Income is not required as the Company does not have any other
comprehensive income and the net return on ordinary activities
after taxation is both the profit and total comprehensive income
for the period.
Balance Sheet
As at 30 April
|
Notes
|
2024
£'000
|
2024
£'000
|
2023
£'000
|
2023
£'000
|
Fixed assets
|
|
|
|
|
|
Investments held at fair value through profit
or loss
|
6
|
|
2,847,068
|
|
2,574,408
|
Current assets
|
|
|
|
|
|
Debtors
|
|
12,506
|
|
20,441
|
|
Cash and cash equivalents
|
|
38,622
|
|
42,191
|
|
|
|
51,128
|
|
62,632
|
|
Creditors
|
|
|
|
|
|
Amounts falling due within one year
|
7
|
(61,987)
|
|
(93,142)
|
|
Net current liabilities
|
|
|
(10,859)
|
|
(30,510)
|
Total assets less current
liabilities
|
|
|
2,836,209
|
|
2,543,898
|
Creditors
|
|
|
|
|
|
Amounts falling due after more than one
year:
|
|
|
|
|
|
Loan notes
|
7
|
(173,176)
|
|
(99,858)
|
|
Provision for tax liability
|
7
|
(1,896)
|
|
(1,160)
|
|
|
|
|
(175,072)
|
|
(101,018)
|
Net assets
|
|
|
2,661,137
|
|
2,442,880
|
Capital and reserves
|
|
|
|
|
|
Share capital
|
8
|
|
12,659
|
|
12,659
|
Share premium account
|
8
|
|
433,714
|
|
433,714
|
Capital redemption reserve
|
|
|
8,700
|
|
8,700
|
Capital reserve
|
8
|
|
2,132,609
|
|
1,915,385
|
Revenue reserve
|
|
|
73,455
|
|
72,422
|
Shareholders' funds
|
|
|
2,661,137
|
|
2,442,880
|
Shareholders' funds per ordinary
share (borrowings at book
value)
|
|
|
1,242.8p
|
|
1,058.5p
|
* See Glossary of
terms and Alternative Performance Measures at the end of this
announcement.
The accompanying notes on the
following pages are an integral part of the Financial
Statements
Statement of Changes in
Equity
For the year ended 30 April 2024
|
Notes
|
Share
capital
£'000
|
Share
premium account
£'000
|
Capital
redemption
reserve
£'000
|
Capital
reserve*
£'000
|
Revenue
reserve
£'000
|
Shareholders'
funds
£'000
|
Shareholders' funds at 1 May
2023
|
|
12,659
|
433,714
|
8,700
|
1,915,385
|
72,422
|
2,442,880
|
Net return on ordinary activities
after taxation
|
|
-
|
-
|
-
|
390,111
|
8,241
|
398,352
|
Ordinary shares bought
back
|
8
|
-
|
-
|
-
|
(172,887)
|
-
|
(172,887)
|
Dividends paid during the
year
|
5
|
-
|
-
|
-
|
-
|
(7,208)
|
(7,208)
|
Shareholders' funds at 30 April 2024
|
|
12,659
|
433,714
|
8,700
|
2,132,609
|
73,455
|
2,661,137
|
For the year ended 30 April 2023
|
Notes
|
Share
capital
£'000
|
Share
premium account
£'000
|
Capital
redemption
reserve
£'000
|
Capital
reserve*
£'000
|
Revenue
reserve
£'000
|
Shareholders'
funds
£'000
|
Shareholders' funds at 1 May
2022
|
|
11,823
|
262,183
|
8,700
|
2,129,483
|
66,975
|
2,479,164
|
Net return on ordinary activities
after taxation
|
|
-
|
-
|
-
|
(78,558)
|
10,714
|
(67,844)
|
Ordinary shares bought
back
|
8
|
-
|
-
|
-
|
(135,221)
|
-
|
(135,221)
|
Ordinary shares issued
|
8
|
836
|
171,531
|
-
|
(319)
|
-
|
172,048
|
Dividends paid during the
year
|
5
|
-
|
-
|
-
|
-
|
(5,267)
|
(5,267)
|
Shareholders' funds at 30 April 2023
|
|
12,659
|
433,714
|
8,700
|
1,915,385
|
72,422
|
2,442,880
|
* The
Capital Reserve balance at 30 April 2024 includes holding gains on
investments of £1,003,962,000 (30 April 2023 - gains of
£660,579,000).
The accompanying notes on the
following pages are an integral part of the Financial
Statements.
Cash Flow Statement
For the year ended 30
April
|
Notes
|
2024
£'000
|
2024
£'000
|
2023
£'000
|
2023
£'000
|
Cash flows
from operating
activities
|
|
|
|
|
|
Net return on ordinary activities before
taxation
|
|
|
401,190
|
|
(65,853)
|
Adjustments to reconcile company
profit before tax to net cash flow from operating
activities
|
Net (gains)/losses on investments
|
|
|
(389,428)
|
|
78,421
|
Currency gains
|
|
|
(1,419)
|
|
(293)
|
Finance costs of borrowings
|
|
|
8,264
|
|
7,225
|
Other capital movements
|
|
|
|
|
|
Decrease/(increase) in accrued
income
|
|
|
1,586
|
|
(70)
|
Increase in debtors
|
|
|
(450)
|
|
(513)
|
Increase/(decrease) in creditors
|
|
|
476
|
|
(357)
|
Taxation
|
|
|
|
|
|
Overseas tax incurred
|
|
|
(2,074)
|
|
(1,575)
|
Cash from
operations*
|
|
|
18,145
|
|
16,985
|
Interest paid
|
|
|
(7,468)
|
|
(7,402)
|
Net cash inflow from operating
activities
|
|
|
10,677
|
|
9,583
|
Cash flows from investing activities
|
|
|
|
|
|
Acquisitions of investments
|
|
(467,866)
|
|
(255,559)
|
|
Disposals of investments
|
|
586,578
|
|
361,027
|
|
Net cash inflow from investing
activities
|
|
|
118,712
|
|
105,468
|
Cash flows from financing activities
|
|
|
|
|
|
Equity dividends paid
|
5
|
(7,208)
|
|
(5,267)
|
|
Ordinary shares bought back and stamp duty
thereon
|
8
|
(175,482)
|
|
(135,014)
|
|
Ordinary shares issued
|
8
|
-
|
|
71,249
|
|
Loan notes issued
|
|
74,388
|
|
-
|
|
Debenture repaid
|
|
-
|
|
(40,000)
|
|
Borrowings repaid
|
|
(25,000)
|
|
-
|
|
Net cash outflow from financing
activities
|
|
|
(133,302)
|
|
(109,032)
|
(Decrease)/increase in cash and cash
equivalents
|
|
|
(3,913)
|
|
6,019
|
Exchange movements
|
|
|
344
|
|
293
|
Cash and cash equivalents at 1 May
|
|
|
42,191
|
|
35,879
|
Cash and cash equivalents at 30
April
|
|
|
38,622
|
|
42,191
|
* Cash
from operations includes dividends received of £29,805,000 (2023 -
£29,285,000) and interest received of £1,669,000 (2023 -
£856,000).
The accompanying notes are an
integral part of the Financial Statements.
Notes to the Financial
Statements
1.
The Financial Statements for the year to 30 April
2024 have been prepared in accordance with FRS 102 'The Financial
Reporting Standard applicable in the UK and Republic of Ireland' on
the basis of the accounting policies set out below which are
unchanged from the prior year and have been applied consistently.
The updates to FRS 102, applicable for financial years starting on
or after 1 January 2025, have been reviewed, but none of the
updates is currently expected to impact the policies below or the
financial statements prepared in accordance with them.
2. Income
|
2024
£'000
|
2023
£'000
|
Income from investments
|
|
|
UK dividends
|
3,309
|
4,688
|
Overseas dividends
|
24,910
|
24,667
|
|
28,219
|
29,355
|
Other income
|
|
|
Deposit interest
|
1,669
|
856
|
Total income
|
29,888
|
30,211
|
Total income comprises:
|
|
|
Dividends from financial assets classified as
at fair value through profit or loss
|
28,219
|
29,355
|
Interest from financial assets not at fair
value through profit or loss
|
1,669
|
856
|
|
29,888
|
30,211
|
Special dividend entitlements
arising in the year amounted to £1,069,000 (2023 -
£492,000).
3. Baillie Gifford & Co Limited, a wholly owned subsidiary of
Baillie Gifford & Co, has been appointed as the Company's
Alternative Investment Fund Manager (AIFM) and Company Secretary.
Baillie Gifford & Co Limited has delegated portfolio management services
to Baillie Gifford & Co. Dealing activity and transaction
reporting have been further sub-delegated to Baillie Gifford
Overseas Limited and Baillie Gifford Asia (Hong Kong) Limited. The
annual management fee payable to Baillie Gifford & Co Limited
is 0.45% on the first £750 million of total assets, 0.33% on the
next £1 billion of total assets and 0.30% on the remaining total
assets. For fee purposes, total assets is defined as the total
value of all assets held less all liabilities (other than any
liability in the form of debt intended for investment purposes) and
excludes the value of the Company's holding in The Schiehallion
Fund, a closed-ended investment company managed by Baillie Gifford
& Co. The Company does not currently hold any other collective
investment vehicles managed by Baillie Gifford & Co. Where the
Company holds investments in open-ended collective investment
vehicles managed by Baillie Gifford, such as OEICs, Monks' share of
any fees charged within that vehicle will be rebated to the
Company. All debt drawn down during the periods under review is
intended for investment purposes. For the quarters to 31 January
2023 and 30 April 2023, the assets subject to management fee
excluded the £173 million rolled into the Company from The
Independent Investment Trust PLC in accordance with the terms of
the transaction.
4. Net Return Per Ordinary
Share
|
2024
Revenue
|
2024
Capital
|
2024
Total
|
2023
Revenue
|
2023
Capital
|
2023
Total
|
Net return after
taxation
|
3.68p
|
174.07p
|
177.75p
|
4.70p
|
(34.47p)
|
(29.77p)
|
Revenue return per ordinary share is
based on the net revenue return on ordinary activities after
taxation of £8,241,000 (2023 - £10,714,000) and on 224,114,021
(2023 - 227,887,889) ordinary shares, being the weighted average
number of ordinary shares in issue during the year.
Capital return per ordinary share is
based on the net capital gain for the financial year of
£390,111,000 (2023 - loss of £78,558,000) and on 224,114,021 (2023
- 227,887,889) ordinary shares, being the weighted average number
of ordinary shares in issue during the year.
There are no dilutive or potentially
dilutive shares in issue.
5. Ordinary Dividends
|
2024
|
2023
|
2024
£'000
|
2023
£'000
|
Amounts recognised as distributions in the
year:
|
|
|
|
|
Previous year's final (paid 13 September
2023)
|
3.15p
|
2.35p
|
7,208
|
5,267
|
We also set out below the total
dividends paid and proposed in respect of the financial year, which
is the basis on which the requirements of section 1158 of the
Corporation Tax Act 2010 are considered. The revenue available for
distribution by way of dividend for the year is £8,241,000 (2023 -
£10,714,000).
|
2024
|
2023
|
2024
£'000
|
2023
£'000
|
Amounts paid and payable in respect of the
financial year
|
|
|
|
|
Proposed final (payable 17 September
2024)
|
2.10p
|
3.15p
|
4,497
|
7,208
|
If approved, the recommended final
dividend on the ordinary shares will be paid on 17 September 2024
to shareholders on the register at the close of business on 9
August 2024. The ex-dividend date is 8 August 2024. The Company's
Registrar offers a Dividend Reinvestment Plan and the final date
for elections for this dividend is 27 August 2024.
6. Fixed Assets - Investments
As at 30 April 2024
|
Level 1
£'000
|
Level 2
£'000
|
Level 3
£'000
|
Total
£'000
|
Listed and suspended equities
|
2,714,161
|
73,796
|
-
|
2,787,957
|
Unlisted securities
|
-
|
-
|
59,111
|
59,111
|
Total financial asset investments
|
2,714,161
|
73,796
|
59,111
|
2,847,068
|
As
at 30 April 2023
|
Level 1
£'000
|
Level 2
£'000
|
Level 3
£'000
|
Total
£'000
|
Listed and suspended equities
|
2,466,713
|
53,277
|
-
|
2,519,990
|
Unlisted securities
|
-
|
-
|
54,418
|
54,418
|
Total
financial asset investments
|
2,466,713
|
53,277
|
54,418
|
2,574,408
|
Investments in securities are
financial assets held at fair value through profit or loss. In
accordance with Financial Reporting Standard 102, the tables above
provide an analysis of these investments based on the fair value
hierarchy described below, which reflects the reliability and
significance of the information used to measure their fair
value.
Level 2 investments comprise the
Company's holding in The Schiehallion Fund. The suspended
investment in Sberbank of Russia has been valued at nil.
The fair value hierarchy used to
analyse the basis on which the fair values of financial instruments
held at fair value through the profit and loss account are measured
is described below. Fair value measurements are categorised on the
basis of the lowest level input that is significant to the fair
value measurement.
Level 1 - using unadjusted
quoted prices for identical instruments in an active
market;
Level 2 - using inputs, other
than quoted prices included within Level 1, that are directly or
indirectly observable (based on market data); and
Level 3 - using inputs that are
unobservable (for which market data is unavailable).
Private Company Investments
Private company investments are
valued at fair value by the Directors following a detailed review
and appropriate challenge of the valuations proposed by the
Managers. The Managers' private company investment policy applies
techniques consistent with the International Private Equity and
Venture Capital Valuation Guidelines 2022 ('IPEV'). The techniques
applied are predominantly market-based approaches. The market-based
approaches available under IPEV are set out below and are followed
by an explanation of how they are applied to the Company's private
company portfolio:
¾
Multiples;
¾
Industry Valuation Benchmarks; and
¾
Available Market Prices.
The nature of the private company
portfolio currently will influence the valuation technique applied.
The valuation approach recognises that, as stated in the IPEV
Guidelines, the price of a recent investment, if resulting from an
orderly transaction, generally represents fair value as at the
transaction date and may be an appropriate starting point for
estimating fair value at subsequent measurement dates. However,
consideration is given to the facts and circumstances as at the
subsequent measurement date, including changes in the market or
performance of the investee company. Milestone analysis is used
where appropriate to incorporate the operational progress of the
investee company into the valuation. Additionally, the background
to the transaction must be considered. As a result, various
multiples-based techniques are employed to assess the valuations
particularly in those companies with established revenues.
Discounted cashflows are used where appropriate. An absence of
relevant industry peers may preclude the application of the
Industry Valuation Benchmarks technique and an absence of
observable prices may preclude the Available Market Prices
approach. All valuations are cross-checked for reasonableness by
employing relevant alternative techniques.
The private company investments are
valued according to a three monthly cycle of measurement dates. The
fair value of the private company investments will be reviewed
before the next scheduled three monthly measurement date on the
following occasions:
¾
at the year end and half year end of the Company;
and
¾
where there is an indication of a change in fair
value as defined in the IPEV guidelines (commonly referred to as
'trigger' events).
7.
Creditors and Provisions include the following:
Borrowing facilities
At 30 April 2024 the Company had a 3
year £150 million unsecured floating rate revolving facility with
National Australia Bank Limited, which expires on 29 November
2024.
At 30 April 2024 drawings were as
follows:
¾
National Australia Bank Limited: £50 million at an
interest rate of 1.4% over SONIA, maturing in October 2024 (2023 -
£75 million at an interest rate of 1.4% over SONIA, maturing in
September 2023).
The main covenants relating to the
above loans are that total borrowings shall not exceed 30% of the
Company's adjusted net asset value and the Company's minimum
adjusted net asset value shall be £650 million.
There were no breaches of loan
covenants during the year to 30 April 2024 (2023 -
none).
Unsecured Loan Notes
The unsecured loan notes are stated
at the cumulative amount of net proceeds after issue expenses. The
cumulative effect is to reduce the carrying amount of borrowings by
£137,000 (2023 - £142,000).
Provision for Tax Liability
The tax liability provision at 30
April 2024 of £1,896,000 (30 April 2023 - £1,160,000) relates to a
potential liability for Indian capital gains tax that may arise on
the Company's Indian investments should they be sold in the future,
based on the net unrealised taxable capital gains at the period end
and on enacted Indian tax rates. The amount of any future tax
amounts payable may differ from this provision, depending on the
value and timing of any future sales of such investments and future
Indian tax rates.
|
Repayment
date
|
Nominal
rate
|
Effective
rate
|
2024
£'000
|
2023
£'000
|
£60 million 1.86% notes 2054
|
7/8/2054
|
1.86%
|
1.86%
|
59,907
|
59,904
|
£40 million 1.77% notes 2045
|
7/8/2045
|
1.77%
|
1.77%
|
39,956
|
39,954
|
¥2,500 million 2.17% notes 2037
|
12/12/2037
|
2.17%
|
2.17%
|
12,687
|
-
|
€18 million 4.55% notes 2035
|
12/12/2035
|
4.55%
|
4.55%
|
15,370
|
-
|
€35 million 4.29% notes 2033
|
12/12/2033
|
4.29%
|
4.29%
|
29,886
|
-
|
€18 million 4.30% notes 2030
|
12/12/2030
|
4.30%
|
4.30%
|
15,370
|
-
|
|
173,176
|
99,858
|
Provision for liability in respect of Indian
capital gains tax
|
1,896
|
1,160
|
|
175,072
|
101,018
|
8. Share Capital
|
2024
Number
|
2024
£'000
|
2023
Number
|
2023
£'000
|
Allotted, called up and fully paid ordinary
shares of 5p each
|
214,130,666
|
10,707
|
230,796,666
|
11,540
|
Treasury shares of 5p each
|
39,040,794
|
1,952
|
22,374,794
|
1,119
|
Total
|
253,171,460
|
12,659
|
253,171,460
|
12,659
|
The Company's authority permits it
to hold shares bought back 'in treasury'. Such treasury shares may
be subsequently either sold for cash (at, or at a premium to, net
asset value per ordinary share) or cancelled. In the year to 30
April 2024, 16,666,000 shares with a nominal value of £833,000 were
bought back at a total cost of £172,887,000 to be held in treasury
(2023 - 13,566,244 ordinary shares with a nominal value of £678,000
were bought back at a total cost of £135,221,000 and held in
treasury). No shares were issued from treasury during the year and
at 30 April 2024 39,040,794 (2023 - 22,374,794) shares were held in
treasury. At 30 April 2024 the Company had authority to buy back
21,178,652 ordinary shares and to allot or sell from treasury
22,988,666 ordinary shares without application of pre-emption
rights. Under the provisions of the Company's Articles of
Association share buy-backs are funded from the capital reserve. In
the period 1 May 2024 to 26 June 2024 the Company bought back a
further 3,515,000 shares with a nominal value of £176,000 at a
total cost of £41,447,000 to be held in treasury. At 26 June 2024
42,555,794 shares were held in treasury and the Company had
authority remaining to buy back a further 17,663,652 ordinary
shares.
9.
The financial information set out above does not constitute the
Company's statutory accounts for the years ended 30 April 2024 or
2023 but is derived from those accounts. Statutory accounts for
2023 have been delivered to the Registrar of Companies and those
for 2024 will be delivered in due course. The auditor has reported
on these accounts; the reports were (i) unqualified, (ii) did not
include a reference to any matters to which the auditor drew
attention by way of emphasis without qualifying their report, and
(iii) did not contain a statement under section 498 (2) or (3) of
the Companies Act 2006.
10. Transactions with Related Parties and the
Managers and Secretaries
No Director has a contract of service
with the Company. During the year no Director was interested in any
contract or other matter requiring disclosure under section 412 of
the Companies Act 2006.
Details of the management fee
arrangements are included in note 3 above.
11. The Annual
Report and Financial Statements will be available on the Managers'
website www.monksinvestmenttrust.co.uk‡
on or around 16 July 2024.
‡ Neither the contents of the Managers' website nor the contents
of any website accessible from hyperlinks on the Managers' website
(or any other website) is incorporated into, or forms part of, this
announcement.
None of the views
expressed in this document should be construed as advice to buy or
sell a particular investment.
Glossary of terms and Alternative Performance Measures
(APM)
An alternative performance measure
is a financial measure of historical or future financial
performance, financial position, or cash flows, other than a
financial measure defined or specified in the applicable financial
reporting framework.
Total assets
This is the Company's definition of
adjusted total assets, being the total value of all assets held
less all liabilities (other than liabilities in the form of
borrowings).
Shareholders' funds
Shareholders' funds is the value of
all assets held less all liabilities, with borrowings deducted at
book cost.
Net liquid assets
Net liquid assets comprise current
assets less current liabilities (excluding borrowings) and
provisions.
Active share (APM)
Active share, a measure of how
actively a portfolio is managed, is the percentage of the portfolio
that differs from its comparative index. It is calculated by
deducting from 100 the percentage of the portfolio that overlaps
with the comparative index. An active share of 100 indicates no
overlap with the index and an active share of zero indicates a
portfolio that tracks the index.
Unlisted, Unquoted and Private Company
Investments
'Unlisted', 'Unquoted' and 'Private
Company' investments are investments in securities not traded on a
recognised exchange.
Net Asset Value (APM)
Net Asset Value (NAV) is the value
of all assets held less all liabilities, with borrowings deducted
at either par value or fair value as described below. Per share
amounts are calculated by dividing the relevant figure by the
number of ordinary shares in issue.
Net Asset Value (borrowings at Par Value)
(APM)
Borrowings are valued at nominal
par value. A reconciliation from shareholders' funds (borrowings at
book value) to net asset value after deducting borrowings at par
value is provided below.
|
2024
£'000
|
2024
per share
|
2023
£'000
|
2023
per share
|
Shareholders' funds (borrowings at
book value)
|
2,661,137
|
1,242.8p
|
2,442,880
|
1,058.5p
|
Add: book value of
borrowings
|
223,176
|
104.2p
|
174,858
|
75.8p
|
Less: par value of
borrowings
|
(223,313)
|
(104.3p)
|
(175,000)
|
(75.8p)
|
Net asset value (borrowings at par
value)
|
2,661,000
|
1,242.7p
|
2,442,738
|
1,058.5p
|
The per share figures above are
based on 214,130,666 (2023 - 230,796,666) ordinary shares of 5p,
being the number of ordinary shares in issue at the year end
excluding treasury shares.
Net Asset Value (borrowings at Fair Value)
(APM)
Borrowings are valued at an
estimate of market worth. The fair values of the loan notes are
calculated using a comparable debt approach, by reference to a
basket of corporate debt. The fair value of the Company's short
term bank borrowings is equivalent to its book value.
A reconciliation from shareholders'
funds (borrowings at book value) to net asset value after deducting
borrowings at fair value is provided below.
|
2024
£'000
|
2024
per share
|
2023
£'000
|
2023
per share
|
Shareholders' funds (borrowings at
book value)
|
2,661,137
|
1,242.8p
|
2,442,880
|
1,058.5p
|
Add: book value of
borrowings
|
223,176
|
104.2p
|
174,858
|
75.8p
|
Less: fair value of
borrowings
|
(173,210)
|
(80.9p)
|
(125,404)
|
(54.3p)
|
Net asset value (borrowings at fair
value)
|
2,711,103
|
1,266.1p
|
2,492,334
|
1,080.0p
|
The per share figures above are
based on 214,130,666 (2023 - 230,796,666) ordinary shares of 5p,
being the number of ordinary shares in issue at the year end
excluding treasury shares.
Discount/premium (APM)
As stock markets and share prices
vary, an investment trust's share price is rarely the same as its
NAV. When the share price is lower than the NAV per share it is
said to be trading at a discount. The size of the discount is
calculated by subtracting the NAV per share from the share price
and is usually expressed as a percentage of the NAV per share. If
the share price is higher than the NAV per share, this situation is
called a premium.
|
|
2024
|
2023
|
Closing NAV per share (borrowings at
par)
|
a
|
1,242.7p
|
1,058.5p
|
Closing NAV per share (borrowings at
fair value)
|
b
|
1,266.1p
|
1,080.0p
|
Closing share price
|
c
|
1,158.0p
|
975.0p
|
Discount to NAV with borrowings at
par
|
(c-a) ÷
a
|
(6.8%)
|
(7.9%)
|
Discount to NAV with borrowings at
fair value
|
(c-b) ÷
b
|
(8.5%)
|
(9.7%)
|
Total return (APM)
The total return is the return to
shareholders after reinvesting the net dividend on the date that
the share price goes ex-dividend, as detailed below.
|
|
2024
NAV
(par)
|
2024
NAV
(fair)
|
2024
Share
price
|
2023
NAV
(par)
|
2023
NAV
(fair)
|
2023
Share
price
|
Closing NAV per share/share
price
|
a
|
1,242.7p
|
1,266.1p
|
1,158.0p
|
1,058.5p
|
1,080.0p
|
975.0p
|
Dividend adjustment
factor*
|
b
|
1.0028
|
1.0028
|
1.0031
|
1.0021
|
1.0021
|
1.0023
|
Adjusted closing NAV per share/share
price
|
c = a x b
|
1,246.2p
|
1,269.6p
|
1,161.6p
|
1,060.7p
|
1,082.3p
|
977.3p
|
Opening NAV per share/share
price
|
d
|
1,058.5p
|
1,080.0p
|
975.0p
|
1,089.0p
|
1,099.8p
|
1,051.0p
|
Total return
|
(c ÷
d)-1
|
17.7%
|
17.6%
|
19.1%
|
(2.6%)
|
(1.6%)
|
(7.0%)
|
* The dividend adjustment factor is calculated on the assumption
that the dividend of 3.15p (2023 - 2.35p) paid by the Company
during the year was reinvested into shares of the Company at the
cum income NAV/share price, as appropriate, at the ex-dividend
date.
Ongoing charges (APM)
The total expenses (excluding
dealing and borrowing costs) incurred by the Company as a
percentage of the daily average net asset value (with borrowings at
fair value), as detailed below.
|
|
2024
|
2023
|
Investment management fee
|
|
£9,431,000
|
£8,878,000
|
Other administrative
expenses
|
|
£1,850,000
|
£1,833,000
|
Total expenses
|
a
|
£11,281,000
|
£10,711,000
|
Average net asset value (with
borrowings deducted at fair value)
|
b
|
£2,589,210,000
|
£2,480,229,000
|
Ongoing charges
|
a ÷
b
|
0.44%
|
0.43%
|
Gearing (APM)
At its simplest, gearing is
borrowing. Just like any other public company, an investment trust
can borrow money to invest in additional investments for its
portfolio. The effect of the borrowing on the shareholders' assets
is called 'gearing'. If the Company's assets grow, the
shareholders' assets grow proportionately more because the debt
remains the same. But if the value of the Company's assets falls,
the situation is reversed. Gearing can therefore enhance
performance in rising markets but can adversely impact performance
in falling markets. The level of gearing can be adjusted through
the use of derivatives which affect the sensitivity of the value of
the portfolio to changes in the level of markets.
Gross gearing, also referred to as
potential gearing is the Company's borrowings expressed as a
percentage of shareholders' funds (a ÷ c in the table
below).
Net gearing, also referred to as
invested or equity gearing is borrowings at book value less cash
and cash equivalents (any certificates of deposit are not deducted)
and brokers' balances expressed as a percentage of shareholders'
funds (b ÷ c in the table below)*.
Effective equity gearing, as
defined by the Board and Managers of Monks, is the Company's
borrowings at par less cash, brokers' balances and investment grade
bonds maturing within one year, expressed as a percentage of
shareholders' funds*.
*
As adjusted to take into account the gearing
impact of any derivative holdings.
|
|
2024
|
2023
|
Borrowings (at book cost)
|
a
|
£223,176,000
|
£174,858,000
|
Less: cash and cash
equivalents
|
|
(£38,622,000)
|
(£42,191,000)
|
Less: sales for subsequent
settlement
|
|
(£9,749,000)
|
(£16,520,000)
|
Add: purchases for subsequent
settlement
|
|
£7,086,000
|
£14,456,000
|
Adjusted borrowings
|
b
|
£181,891,000
|
£130,693,000
|
Shareholders' funds
|
c
|
£2,661,137,000
|
£2,442,880,000
|
Gross (potential) gearing
|
a ÷
c
|
8.4%
|
7.2%
|
Net (equity) gearing
|
b ÷
c
|
6.8%
|
5.3%
|
Leverage (APM)
For the purposes of the Alternative
Investment Fund Managers (AIFM) Regulations leverage is any method
which increases the Company's exposure, including the borrowing of
cash and the use of derivatives. It is expressed as a ratio between
the Company's exposure and its net asset value and can be
calculated on a gross and a commitment method. Under the gross
method, exposure represents the sum of the Company's positions
after the deduction of sterling cash balances, without taking into
account any hedging and netting arrangements. Under the commitment
method, exposure is calculated without the deduction of sterling
cash balances and after certain hedging and netting positions are
offset against each other.
Compound annual return (APM)
The compound annual return converts
the return over a period of longer than one year to a constant
annual rate of return applied to the compounded value at the start
of each year.
Treasury shares
The Company has the authority to
make market purchases of its ordinary shares for retention as
treasury shares for future reissue, resale, transfer, or for
cancellation. Treasury shares do not receive distributions and the
Company is not entitled to exercise the voting rights attaching to
them.
Turnover (APM)
Turnover is a measure of portfolio
change or trading activity. Monthly turnover is calculated as the
minimum of purchases and sales in a month, divided by the average
market value of the fund. Monthly numbers are added together to get
the rolling 12 month turnover data.
Contingent value rights
'CVR' after an instrument name
indicates a security, usually arising from a corporate action such
as a takeover or merger, which represents a right to receive
potential future value, should the continuing company achieve
certain milestones. The Illumina CVR was received on Illumina's
takeover of the Company's private company investment in GRAIL and
the Abiomed CVR arose on Johnson & Johnson's takeover of
Abiomed. In both cases the milestones relate to the performance of
the technologies acquired through those takeovers. Any values
attributed to these holdings reflect both the amount of the future
value potentially receivable and the probability of the milestones
being met within the time frames in the CVR agreement.
None of the views expressed in this
document should be construed as advice to buy or sell a particular
investment.
‡
Neither the contents of the Managers' website nor
the contents of any website accessible from hyperlinks on the
Managers' website (or any other website) is incorporated into, or
forms part of, this announcement.
Third Party Data Provider
Disclaimer
No third party data provider
('Provider') makes any warranty, express or implied, as to the
accuracy, completeness or timeliness of the data contained herewith
nor as to the results to be obtained by recipients of the
data.
No Provider shall in any way be
liable to any recipient of the data for any inaccuracies, errors or
omissions in the index data included in this document, regardless
of cause, or for any damages (whether direct or indirect) resulting
therefrom.
No Provider has any obligation to
update, modify or amend the data or to otherwise notify a recipient
thereof in the event that any matter stated herein changes or
subsequently becomes inaccurate. Without limiting the foregoing, no
Provider shall have any liability whatsoever to you, whether in
contract (including under an indemnity), in tort (including
negligence), under a warranty, under statute or otherwise, in
respect of any loss or damage suffered by you as a result of or in
connection with any opinions, recommendations, forecasts,
judgements, or any other conclusions, or any course of action
determined, by you or any third party, whether or not based on the
content, information or materials contained herein.
FTSE Index Data
London Stock Exchange Group plc and
its group undertakings (collectively, the 'LSE Group'). © LSE Group
2024. FTSE Russell is a trading name of certain of the LSE Group
companies. 'FTSE®' 'Russell®', 'FTSE Russell®', is/are a trade
mark(s) of the relevant LSE Group companies and is/are used by any
other LSE Group company under license. All rights in the FTSE
Russell indexes or data vest in the relevant LSE Group company
which owns the index or the data. Neither LSE Group nor its
licensors accept any liability for any errors or omissions in the
indexes or data and no party may rely on any indexes or data
contained in this communication.
No further distribution of data
from the LSE Group is permitted without the relevant LSE Group
company's express written consent. The LSE Group does not promote,
sponsor or endorse the content of this communication.
Sustainable Finance Disclosure
Regulation ('SFDR')
The EU Sustainable Finance
Disclosure Regulation ('SFDR') does not have a direct impact in the
UK due to Brexit, however, it applies to third-country products
marketed in the EU. As The Monks Investment Trust PLC is marketed
in the EU by the AIFM, Baillie Gifford & Co Limited, via the
National Private Placement Regime ('NPPR') the following
disclosures have been provided to comply with the high-level
requirements of SFDR.
The AIFM has adopted Baillie
Gifford & Co's stewardship principles and guidelines as its
policy on integration of sustainability risks in investment
decisions. Baillie Gifford & Co believes that a company cannot
be financially sustainable in the long run if its approach to
business is fundamentally out of line with changing societal
expectations. It defines 'sustainability' as a deliberately broad
concept which encapsulates a company's purpose, values, business
model, culture, and operating practices.
Baillie Gifford & Co's approach
to investment is based on identifying and holding high quality
growth businesses that enjoy sustainable competitive advantages in
their marketplace. To do this it looks beyond current financial
performance, undertaking proprietary research to build up an
in-depth knowledge of an individual company and a view on its
long-term prospects. This includes the consideration of
sustainability factors (environmental, social and/or governance
matters) which it believes will positively or negatively influence
the financial returns of an investment.
The likely impact on the return of
the portfolio from a potential or actual material decline in the
value of investment due to the occurrence of an environmental,
social or governance event or condition will vary and will depend
on several factors including but not limited to the type, extent,
complexity and duration of an event or condition, prevailing market
conditions and existence of any mitigating factors.
Whilst consideration is given to
sustainability matters, there are no restrictions on the investment
universe of the Company, unless otherwise stated within in its
investment objective & policy. Baillie Gifford & Co can
invest in any companies it believes could create beneficial
long-term returns for investors. However, this might result in
investments being made in companies that ultimately cause a
negative outcome for the environment or society.
More detail on the Manager's
approach to sustainability can be found in the stewardship
principles and guidelines document, available publicly on the
Baillie Gifford website bailliegifford.com.
The underlying investments do not
take into account the EU criteria for environmentally sustainable
economic activities established under the EU Taxonomy
Regulation.
-ends-